Janux Therapeutics, Inc.JANXNASDAQ
LOADING
|||
Price to Sales: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-sales ratio
Latest
271.80
↑ 164% above average
Average (5y)
102.90
Historical baseline
Range
High:271.80
Low:0.00
Volatility
264.1%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 271.80 | +365.2% |
| 2023 | 58.43 | -7.9% |
| 2022 | 63.42 | -71.7% |
| 2021 | 223.74 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |